Putnam Investments
@PutnamToday
Followers
33K
Following
139
Media
1K
Statuses
5K
Diversified equity-only asset manager since 1937. Putnam Investments is a Franklin Templeton company. See https://t.co/lpGwlywJZv for more information.
Click for important disclosure
Joined June 2009
Read the latest Equity Insights from Putnam at https://t.co/Bm8hOzSAwR for an outlook on equity markets in the year ahead.
1
0
0
Putnam Chief Investment Officer Shep Perkins, CFA, shares his outlook for equity markets in the year ahead. Read his insights at https://t.co/Bm8hOzSAwR.
0
0
1
Read the latest Equity Insights from Putnam at https://t.co/4YTTQOgGWO for an outlook on equity markets.
3
0
0
Putnam Chief Investment Officer Shep Perkins, CFA, shares his outlook for equity markets in the months ahead. Read his insights at https://t.co/4YTTQOgGWO.
0
2
1
Read the latest Equity Insights from Putnam at https://t.co/YbahL9OdWw for perspective on non-US equity markets.
0
0
1
Putnam Portfolio Manager Vivek Gandhi, CFA, shares his views on the potential in stocks outside US markets. Read his insights at https://t.co/YbahL9OdWw
0
0
0
Companies with the ability to grow income, in many cases, also successfully grow earnings and revenue. Go to https://t.co/hA4rFmRqbS to learn why Putnam’s Large Cap Value managers focus on companies that are positioned to increase their dividends.
2
0
4
Putnam’s Large Cap Value managers discuss their approach to dividend investing and finding opportunities for value investors. Read their perspective at https://t.co/hA4rFmRqbS.
1
0
1
Putnam’s Large Cap Value managers discuss how they evaluate dividends and why they look beyond the highest yielders for opportunities. Read their insights at https://t.co/hA4rFmRqbS.
2
0
2
Putnam Analyst Noelle Tune, MD, explains why unmet needs should be a key area of focus when investing in biotech. Read her perspective at https://t.co/5Kbbw3rGqA.
0
0
0
Putnam Analyst Noelle Tune, MD, shares her views on the most compelling biotech opportunities at https://t.co/5Kbbw3r8B2.
0
0
1
Putnam Analyst Noelle Tune, MD, explains why unmet needs should be a key area of focus when investing in biotech. Read her perspective at https://t.co/LiAbwfavPN.
0
0
0
Learn why Putnam Analyst Noelle Tune, MD, is optimistic about investing in biotech at https://t.co/LiAbwfavPN.
1
0
0
We mark the passing of Jimmy Carter, 39th president of the United States. A peacemaker, a humanitarian, and a dignified American, he showed us that the power of the presidency extends far past one's time in office and reaches millions in meaningful ways.
5
0
2
Putnam Portfolio Manager Mike Petro highlights the features of business development companies, and provides his outlook for them in a changing economic environment at https://t.co/bURzrZvP1o.
2
0
0
Learn more about the investment potential in business development companies from Putnam Portfolio Manager Mike Petro at https://t.co/bURzrZvP1o.
1
0
0
Business development companies have been a top-performing income-producing asset class in 2024. Can they maintain that strength? Putnam Portfolio Manager Mike Petro offers his views at https://t.co/bURzrZvP1o.
0
0
0
Putnam CIO Shep Perkins discusses promising trends for US equity markets in 2025. Read his 2025 outlook at https://t.co/mBJX0mYE1w.
0
0
0
In his outlook for equity markets, Putnam CIO Shep Perkins suggests looking for clues from an earlier decade. Read his commentary at https://t.co/mBJX0mYE1w.
0
0
1
Go to https://t.co/IrQWl5NET7 to learn more about the subscription economy from Putnam’s Large Cap Growth managers.
0
0
0